Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Graphic Packaging Holding Company Q1 2026 Earnings Call - Shifting from Investment to Cash Harvesting
Graphic Packaging delivered a resilient start to 2026, with Q1 net sales up 2% to $2.2 billion and adjusted EBITDA of $232 million, despite significant headwinds from severe weather, higher maintenanc...
- Q1 2026 net sales increased 2% year-over-year to $2.2 billion, driven by a 1% volume increase and a $50 million favorable foreign exchange impact, though pricing declined 2% due to competitive pressures and index lags.
- Adjusted EBITDA came in at $232 million, down from the prior year period, as the company absorbed $85 million in unfavorable net performance from severe weather disruptions, higher scheduled maintenance, and inventory-related production curtailments.
- Graphic Packaging is transitioning from a capital-intensive investment phase to a cash harvesting cycle, reaffirming full-year 2026 adjusted free cash flow guidance of $700 million to $800 million, which will be used to pay down approximately $500 million in debt.
- +7 more takeaways
Harley-Davidson Q1 2026 Earnings Call - 'Back to the Bricks' Strategy Launches with Sportster Return and $350M EBITDA Target
Harley-Davidson delivered a mixed Q1 2026 report, with global retail sales rising 8% and U.S. market share climbing to 38%, even as consolidated revenue fell 12% and operating income collapsed to $23 ...
- Global retail motorcycle sales rose 8% year-over-year in Q1 2026, driven by a 14% U.S. retail gain that lifted Harley's domestic market share to 38%, up 2 percentage points.
- Consolidated revenue fell 12% to approximately $1.3 billion, primarily because HDFS revenue plunged 54% after the company sold a large portion of its retail loan book and moved to a capital-light forward-flow model.
- HDFS operating income came in at $22 million with a 19.9% margin, while credit loss ratios improved to 3.6%, signaling a cleaner, more manageable balance sheet under the new structure.
- +7 more takeaways
Ecovyst Q1 2026 Earnings Call - Adjusted EBITDA Surges 87% on Refinery Strength and Aggressive Buybacks
Ecovyst delivered a blistering start to 2026, with first-quarter adjusted EBITDA jumping 87% to $40 million, driven by record refinery utilization and a full year of contribution from the Waggaman sul...
- First-quarter adjusted EBITDA surged 87% year-over-year to $40 million, significantly outpacing prior guidance due to unexpected volume strength in regeneration services and favorable pricing dynamics.
- Ecovyst repurchased $36 million in shares during Q1, demonstrating aggressive capital allocation while maintaining a robust $237 million liquidity position and a net debt leverage ratio of 1.2x.
- The company announced a $190 million agreement to acquire Calabrian, a leading North American producer of sulfur dioxide and derivatives, expanding its portfolio into mining, water treatment, pharma, and food processing.
- +7 more takeaways
CytomX Therapeutics Q1 2026 Earnings Call - Varseta-M Dose Optimization Complete, Cash Runway Extended to 2028
CytomX Therapeutics closed Q1 2026 with $346.7 million in cash, extending its runway into late 2028, while completing enrollment in the 40-patient dose optimization cohorts for Varseta-M, its first-in...
- CytomX ended Q1 2026 with $346.7 million in cash and investments, up from $137.1 million at year-end 2025.
- The company projects a cash runway extending into the second half of 2028.
- Varseta-M dose optimization cohorts are fully enrolled with 40 patients across 8.6 and 10 mg/kg doses.
- +17 more takeaways
Southwest Gas Holdings Q1 2026 Earnings Call - Great Basin Demand Surges 8x, Guided for Steady Growth
Southwest Gas Holdings delivered a solid Q1 2026, reporting EPS of $1.91, driven by robust customer growth, lower interest expenses from debt payoff, and strong operational margins. The company affirm...
- Q1 2026 EPS from continuing operations reached $1.91, up from $1.86 in Q1 2025, supported by lower interest expenses following the payoff of all Holdco debt and strong utility performance.
- Management affirmed full-year 2026 Adjusted EPS guidance of $4.17 to $4.32 and long-term earnings growth of 12%-14%, citing constructive regulatory environments and disciplined capital investment.
- The Great Basin 2028 expansion open season was massively oversubscribed, receiving bids for 2.5 billion cubic feet per day against an available design capacity of just over 0.3 billion cubic feet per day, indicating strong regional demand.
- +7 more takeaways
Tandem Diabetes Care Q1 2026 Earnings Call - Record Shipments and PayGo Pharmacy Shift Drive Strong Financials
Tandem Diabetes Care delivered a strong Q1 2026, setting new records for pump shipments (over 29,000) and sales ($247 million), driven by international expansion and a strategic shift toward a pharmac...
- Tandem Diabetes Care reported record Q1 2026 pump shipments of over 29,000 and total sales of $247 million, reflecting strong global momentum.
- U.S. pump shipments grew approximately 10% year-over-year, with U.S. sales reaching $161 million, up 7% year-over-year.
- International sales totaled $86 million, a 3% year-over-year increase, driven by the launch of direct commercial operations in the UK, Switzerland, and Austria.
- +7 more takeaways
Palladyne AI Q1 2026 Earnings Call - Decentralized Swarm Tech Gains Traction Amid Defense Spending Surge
Palladyne AI delivered a strong first quarter with revenue jumping 107% year-over-year to $3.5 million, driven by post-acquisition manufacturing and engineering services. The company exited the quarte...
- Revenue surged 107% year-over-year to $3.5 million, aligning with internal expectations despite a federal government shutdown delaying some defense program activity.
- Backlog grew to $17 million from $13.5 million, with $7 million in new contract awards added during the quarter, providing visibility into future revenue.
- Management reiterated full-year 2026 revenue guidance of $24 million to $27 million, implying 357%-415% growth over 2025, with sequential quarterly acceleration expected.
- +7 more takeaways
Turkcell Q1 2026 Earnings Call - Nationwide 5G Launch Drives Revenue Growth and Market Dominance
Turkcell delivered a strong Q1 2026 performance, marked by the nationwide launch of 5G services and robust revenue growth exceeding TRY 68 billion, up 9% year-over-year. The company secured a leading ...
- Nationwide 5G Launch: Turkcell successfully launched 5G services across all 81 Turkish cities on March 31, 2026, boasting speeds exceeding 2,000 Mbps and securing 40% of available spectrum, reinforcing its market leadership.
- Revenue Growth: Group revenues grew 9% year-over-year to TRY 68 billion, driven by operational discipline, strategic execution, and strong performance in Digital Business Services and the Techfin segment.
- Subscriber Acquisition: Achieved 661,000 postpaid net additions, the highest in 14 quarters, with postpaid subscriber share rising 4.6 points year-over-year to 81%, reflecting targeted offers and high-value customer focus.
- +7 more takeaways
Crinetics Pharmaceuticals Q1 2026 Earnings Call - PALSONIFY Launch Gains Momentum with Strong Patient Adoption and Pipeline Progress
Crinetics Pharmaceuticals delivered a robust first quarter for its acromegaly drug PALSONIFY, securing 232 new patient enrollments and generating $10.3 million in net product revenue. The launch is ra...
- PALSONIFY generated $10.3 million in net product revenue in Q1 2026, contributing to $10.7 million in total revenue.
- The company secured 232 new patient enrollment forms in Q1, indicating strong initial demand and market penetration.
- Treatment-naive patient enrollments increased from 5% in Q4 2025 to 15% in Q1 2026, signaling growing physician confidence in first-line use.
- +7 more takeaways
Thomson Reuters Q1 2026 Earnings Call - Fiduciary-Grade AI Drives 8% Organic Growth and 10% Margin Expansion
Thomson Reuters delivered a strong start to 2026 with first quarter organic revenue growth of 8%, outpacing the prior 7% full-year 2025 rate. The Big Three segments led the charge with 9% growth, fuel...
- First quarter organic revenue grew 8%, exceeding the 7% rate seen in full-year 2025 and driven by strong demand across the Big Three segments.
- Legal Professionals revenue grew 9%, with growth excluding government accelerating to 11% due to robust adoption of Westlaw Advantage and CoCounsel.
- Tax, Audit, and Accounting organic revenue increased 10%, supported by CoCounsel Tax and Audit, SafeSend, and international growth, despite a temporary revenue recognition shift.
- +7 more takeaways